Solving Unmet Problems in Urology with Minimally Invasive Local Drug Delivery
Welcome. We’re Resurge Therapeutics, founded by an experienced team in drug delivery and urology. Our lead pipeline candidate is a new drug delivery product for treatment of lower urinary tract symptoms caused by an enlarged prostate, a condition known as benign prostatic hyperplasia. Curious to find out more? Browse through our website, and get in touch if you would like to request more information.
Benign Prostatic Hyperplasia
Benign Prostatic Hyperplasia, BPH, is a very common condition that affects aging men. The prostate enlarges with age and compresses the urethra which causes negative quality of life urination symptoms. It may also cause bladder or kidney problems. Approximately 40 million men in the US have BPH.
1. Vuichoud C and Loughlin KR. Can J Urol 2015.
Advanced Drug Delivery Solutions
Smart local drug delivery solutions are at the core of all that we do at Resurge Therapeutics. Our main goal is finding smart ways of delivering drugs to more efficiently treat local diseases without the side effects and compliance requirements of oral and systemic medications. Get in touch to set up a meeting with one of our representatives to learn more about our technology and its urology applications.
Resurge Therapeutics mission is to provide true minimally invasive drug delivery solutions for urology.